# A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy

> **NCT01245660** · EARLY_PHASE1 · TERMINATED · sponsor: **University Hospital, Bordeaux** · enrollment: 3 (actual)

## Conditions studied

- Bladder Carcinoma
- Infiltrative Bladder Carcinoma
- Cystectomy

## Interventions

- **DRUG:** LAPATINIB

## Key facts

- **NCT ID:** NCT01245660
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The rythm of enrollment was not compatible with the objective of recruitement in the research.
- **Last updated:** 2013-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245660, "A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01245660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*